Online HRT Payment Plans: Who Actually Offers Them, and What Hits Your Card First
Compare the charge, not just the monthly number
Sort care-only visits, subscriptions, medication bundles, insurance, financing, and Medicare payment options before authorizing a charge.
The HRT Index may earn a commission from some providers named on this page. Sponsored links are labeled where they appear. Commercial relationships do not change the prices, exclusions, refund terms, or regulatory labels we publish.
Online HRT payment plans are rare: of 15 US provider sites checked on August 26, 2026, only Somira publicly showed Klarna, Affirm and Afterpay, and only on quarterly plans. Before financing, compare the first charge, 90-day total, cancellation deadline, insurance, and Medicare’s separate prescription-payment option.
The HRT Index is the independent decision resource for online menopause and HRT care — comparing telehealth providers on clinical legitimacy, care quality, medication fit, price transparency, and access, with every claim verified and dated, so women can choose the path that fits their situation before their first consult.
The better news is that four routes often beat financing because they lower the cost instead of merely spreading it: insurance-billed care, manufacturer savings, generic prescriptions filled outside a subscription, and a pause before the next renewal. On one provider’s public price table, choosing quarterly instead of three monthly charges cuts the three-month total by about 17% to 41%.
Best for you if…
- You already want to explore menopause care and money is the last thing in the way.
- You saw a monthly price, reached checkout, and found a much bigger number.
- You are comparing an insurance clinic with a cash-pay subscription.
- You have HSA or FSA money and need to know what documentation to keep.
- You are on Medicare and want to spread covered prescription costs without confusing that option with telehealth financing.
Not for you if…
- You need a diagnosis or treatment recommendation. That belongs with a licensed clinician.
- You want a guaranteed insurance quote. Only your plan can give you that.
- You are shopping for men’s testosterone therapy. Testosterone is a Schedule III controlled substance in the United States, requires a prescription, and must be prescribed by an appropriately licensed clinician under applicable federal and state rules.
- You have unexplained bleeding after menopause or another situation that needs an in-person evaluation before an online purchase decision.
What does “payment plan” mean on an online HRT page?
Providers use “plan” for three different things: financing, a recurring subscription, and the clinical treatment plan written by a prescriber. Only the first is a payment plan in the ordinary sense. Before comparing prices, identify the billing structure, the charge due today, the next processing date, and what remains owed if treatment stops.
| What the page says | What it usually means | The question that exposes the real cost |
|---|---|---|
| “$X per month” | A true monthly charge, a 28-day charge, or a monthly equivalent for a longer term | “What exact amount is charged today?” |
| “Save with 3 or 12 months” | Multi-month prepayment or a longer commitment | “Is the full term charged now, or is it split?” |
| “Insurance accepted” | The clinic bills the plan; your share depends on copay, deductible, coinsurance, network, and coding | “What is my estimated responsibility after benefits are checked?” |
| “Medication included” | One price covers specified care and medication | “Are labs, progesterone, dose changes, shipping, and a second prescription included?” |
| “Klarna, Affirm, or pay later” | A third-party lender pays the merchant and you repay the lender | “What is the APR, total repayment, first payment, and refund process?” |
| “Cancel anytime” | You may stop a future renewal if you beat the processing deadline | “What becomes nonrefundable once the order starts processing?” |
The line worth writing down: a monthly equivalent tells you what a price averages to. It does not tell you what hits your card today.
Do online HRT payment plans actually exist?
Yes, but the literal answer is narrow. In our August 26, 2026 review of 15 US online menopause and hormone-care provider sites, Somira was the only one publicly displaying Klarna, Affirm, and Afterpay, and it displayed them on quarterly plans. Every other “no” below means no public option found—not a guarantee about a private checkout.
| Provider site checked | Public installment option found? | What the public site showed |
|---|---|---|
| Somira Health | Yes—quarterly plans | Klarna, Affirm, and Afterpay displayed with quarterly women’s-health plans |
| Winona | No | Winona says it cannot accept CareCredit; no Klarna, Affirm, or Afterpay published |
| Midi Health | No | Insurance billing and self-pay visits, not financing |
| Hers | None published for menopause HRT | Monthly equivalents tied to 12-month plans; exact checkout charge must be confirmed |
| Sesame | None published | Monthly menopause care; medication is separate |
| Alloy | None published | Quarterly medication billing, not financing |
| Inner Balance / Oestra | None published | Monthly billing with a six-month introductory period |
| Wisp | None published | One payment for three months of clinician access; medication separate |
| Evernow | None published | Monthly, three-month, and annual care plans; medication separate |
| Stella | None published | Per-visit self-pay pricing and possible insurance reimbursement |
| Elektra Health | None published | Insurance-billed or per-visit self-pay care |
| MyMenopauseRx | None published | Insurance-billed or $150 self-pay visits; medication and labs separate |
| Gennev | None published | Per-visit care with insurance or self-pay |
| Henry Meds | None published | Recurring medication program |
| 1st Optimal | None published | Monthly billing with a published minimum commitment; public price not found |
“None published” is not the same as “impossible.” A checkout can expose a lender or wallet option that never appears on the marketing site. The responsible question is not “Did a comparison page say no?” It is: “What exact choices appear in my checkout, and what will each choice cost in total?”
And one thing we will not do: we are not recommending Somira merely because it answers the literal financing question. We are reporting it because leaving out the only public answer would be dishonest. Somira says its medications are fulfilled through US 503A pharmacy partners and warns that compounded medications are not FDA-approved. Its public page does not make the FDA status of every individual SKU clear enough for us to award it a recommendation.
The right online HRT provider isn't the same for every woman — it depends on your symptoms, your age and whether you have a uterus, your medication route preference (patch, pill, gel, or vaginal estrogen), your risk history, your insurance or cash-pay situation, and your state. Some situations belong with an in-person clinician first. Because a general answer can't resolve those for you, use The HRT Index's Find My HRT Path tool to match your situation to the right provider — and to flag when online care isn't the right starting point — before your first consult.
→ Find the payment route that fits your situation — about 90 seconds, no email required.
What did we actually verify?
We opened the public pricing, product, insurance, FAQ, terms, cancellation, refund, and HSA/FSA pages used in this comparison and recorded what they published on August 26, 2026. We also checked primary government, medical-society, lender, and manufacturer sources for the regulatory, tax, credit, Medicare, and savings-program claims.
We did not complete a provider intake or checkout, apply for credit, submit an insurance claim, or receive treatment. Those limits matter. Where a price can only be confirmed after intake or checkout, the comparison says unknown—confirm at checkout instead of manufacturing a number.
Corrections and source challenges: partners@thehrtindex.com. We publish dated corrections.
What are the six ways to pay for online menopause care?
There are six payment structures in this market: recurring subscription, multi-month prepayment, insurance-billed visit, medication bundle, third-party financing, and Medicare’s prescription-payment option. They are not interchangeable. One can lower price, another only changes timing, and a loan can keep collecting after a provider has stopped shipping or treating you.
| Structure | How it works | Examples | The catch |
|---|---|---|---|
| Monthly or 28-day subscription | Recurs until you cancel or pause | Sesame, Inner Balance, Winona | A 28-day cycle creates about 13.04 charges per year; a processed charge is usually not refundable |
| Multi-month prepayment | You pay for several months at once | Alloy quarterly, Somira quarterly, Evernow annual; Hers advertises 12-month-plan equivalents | The low monthly number may not be the amount due today |
| Insurance-billed visit | The clinic bills your medical plan | Midi, MyMenopauseRx, Elektra, Gennev | Your final responsibility can arrive after the claim is adjudicated |
| Bundled medication program | Care and specified medication share one recurring price | Winona, Alloy, Inner Balance, Henry Meds | Labs, a second prescription, dose increases, or shipping upgrades may sit outside the bundle |
| Third-party financing | A lender pays the provider and you repay the lender | Somira quarterly plans | The loan does not stop when treatment stops |
| Medicare Prescription Payment Plan | A Part D plan spreads covered drug out-of-pocket costs across the calendar year | All Medicare drug plans offer it | It does not lower the total and does not cover telehealth visit or subscription fees |
What will each online HRT provider charge first?
The first known charge ranges from $49 for Evernow’s monthly care plan to $420 for its annual plan among public figures we verified; care-only and medication-inclusive prices buy different things. The ledger below separates the advertised monthly number, the first known charge, the known 90-day obligation, medication inclusion, and the catch most likely to surprise you.
| Provider | Public price verified August 26, 2026 | First known charge | Known or scheduled first-90-day charge | Medication included? | The catch |
|---|---|---|---|---|---|
| Somira | Patch: $99.99/month equivalent quarterly or $159.99 monthly | $299.99 on quarterly patch plan | $299.99 | Yes | BNPL appears on quarterly plans; SKU-level FDA status is not clear enough to generalize |
| Winona | Patch $149 every 28 days; progesterone capsules $39 every 28 days | $149, or $188 for patch plus progesterone | $596, or $752 with progesterone, if charges process on days 0, 28, 56, and 84 | Yes | No CareCredit; 24-hour refund window after processing begins |
| Alloy | Patch $100/month equivalent plus $49 one-time consult | About $349 | About $349 | Yes | One-month price is billed as a three-month supply; consult fee is separate |
| Hers | Oral from $79/month; patch from $134/month, each with a 12-month plan | Unknown—confirm at checkout | Unknown—confirm at checkout | Yes | Hers publishes monthly equivalents but not a universal amount due today |
| Inner Balance / Oestra | $199/month for six months, then $99.50/month | $199 | $597 | Yes—compounded | First six months total $1,194; dose adjustments may cost extra; pharmacy-status pages conflict |
| Henry Meds | Women’s hormone program $149/month | $149 | $447 | Yes | The program may use FDA-approved or compounded products; confirm the prescribed product |
| 1st Optimal | Public price not found | Unknown—confirm before enrollment | Unknown | Program-dependent | Terms publish a minimum 120-day commitment and monthly billing |
| Midi | $250 first self-pay visit; $150 returning | $250, or plan cost-sharing | $250 unless a follow-up is booked | No | Medication and labs are separate; insurance responsibility depends on the plan |
| Sesame | $59/month menopause care | $59 | $177 | No | Medication is paid at the local pharmacy; basic labs are included only when ordered and available under the program’s terms |
| Wisp | $99 once for three months of care access | $99 | $99 | No | Medication is paid at the local pharmacy |
| Evernow | $49 monthly; $129 for three months; $420 annual | $49, $129, or $420, depending on plan | $147, $129, or $420 | No | Annual fee is billed at checkout; medication is separate |
| MyMenopauseRx | $150 per self-pay virtual visit | $150, or plan cost-sharing | $150 unless another visit is booked | No | Prescriptions and labs are separate; current pages publish conflicting late-cancel/no-show fees |
| Elektra | $250 initial; $150 follow-up self-pay | $250, or plan cost-sharing | Depends on whether follow-up is scheduled | No | Insurance participation and public-program availability depend on state and plan |
| Gennev | Physician visit $250 initial; $199 follow-up | $250, or plan cost-sharing | Depends on whether follow-up is scheduled | No | Medication and labs are separate |
| Stella | $200 initial; $90 follow-up | $200 | Depends on whether follow-up is scheduled | No | Stella says it can provide a superbill for possible reimbursement |
“Known 90-day charge” means the amount scheduled by the published billing cadence, not a prediction of clinical follow-up, taxes, shipping upgrades, pharmacy prices, insurance adjudication, or financing terms. The Winona figures assume the first 28-day charge occurs on day 0; the fourth charge falls on day 84.
→ See the full online HRT cost guide before comparing two “monthly” prices that cover different services.
Which “monthly” HRT prices are not really monthly?
A monthly equivalent can hide a quarterly shipment, a 12-month plan, a six-month introductory period, or a 28-day refill cycle. None of those structures is automatically bad. The problem begins when the headline number is mistaken for the amount charged today or for a true calendar-month cost. These five examples show why the interval belongs beside the price.
| Advertised number | What the public terms actually show | Practical meaning |
|---|---|---|
| Alloy patch: $100/month | $49 one-time consult plus a three-month patch supply billed together | First known outlay is about $349, not $100 |
| Hers: from $79/month oral or $134/month patch | Each is stated with a 12-month plan | Exact charge due today is not public; confirm before authorizing payment |
| Inner Balance: then $99.50/month | $199/month for the first six months | $1,194 is charged before the lower rate begins |
| Winona patch: $149 | A 30-day supply is processed every 28 days | About 13.04 charges/year, or roughly $1,942.32/year and $161.86/calendar month |
| Evernow annual: $35/month equivalent | $420 annual fee billed at checkout and every 12 months | $420 is the first charge, not $35 |
None of this is a scandal. Quarterly billing can be cheaper, and a predictable 28-day refill can prevent gaps. The damaging part is pretending the interval does not matter. It matters the moment rent, groceries, or another medical bill lands in the same week.
Is it cheaper to pay monthly or quarterly for online HRT?
At Somira—the provider in our census publishing both monthly and quarterly prices—the quarterly route reduces the three-month total by about 17% to 41%, depending on the product. The correct denominator is the cost of three monthly charges. Using the quarterly total as the denominator makes the monthly premium look smaller than it is.
| Somira product | Quarterly plan | Three monthly charges | Dollar reduction with quarterly | Reduction versus three monthly charges |
|---|---|---|---|---|
| Estradiol tablets | $204.99 | $344.97 | $139.98 | 40.58% |
| Estradiol patches | $299.99 | $479.97 | $179.98 | 37.50% |
| Estradiol gel | $359.99 | $569.97 | $209.98 | 36.84% |
| Vaginal cream | $265.99 | $449.97 | $183.98 | 40.89% |
| Progesterone tablets | $264.99 | $386.97 | $121.98 | 31.52% |
| Progesterone capsules | $289.99 | $416.97 | $126.98 | 30.45% |
| Bi-Est cream with progesterone | $419.99 | $509.97 | $89.98 | 17.64% |
| Bi-Est cream without progesterone | $399.99 | $479.97 | $79.98 | 16.66% |
Source: Somira’s public women’s-health price table, verified August 26, 2026. Calculations compare one quarterly charge with three published monthly charges. They do not include lender interest, fees, taxes, or checkout-specific changes.
The patch example is the cleanest: $299.99 quarterly versus $479.97 across three monthly charges—a $179.98 reduction. Somira displays lenders beside the quarterly route, but that does not guarantee a particular product, schedule, approval, APR, or credit limit. Do not turn the quarterly total into four imaginary payments. Let the lender’s actual checkout disclosure tell you the schedule.
Somira also states that its Bi-Est creams ship monthly even when purchased on a quarterly plan because of beyond-use dating. That is a shipping detail, not a new monthly charge, but it is exactly the kind of detail a comparison page should not bury.
The rule to keep: compare the total for the same period. Never compare a one-month charge with a three-month charge and call the lower number cheaper.
The damaging admission about Winona—the provider relationship we refuse to hide
Winona does not publish a payment plan. It says it cannot accept CareCredit. We found no public Klarna, Affirm, or Afterpay option. It processes 30-day supplies every 28 days, which means about 13.04 charges per year, and its refund window closes after the published 24-hour processing period.
If you literally need to split a lump sum, Winona is the wrong door. Somira is the public financing answer we found, and The HRT Index has no commercial relationship with Somira.
Commercial relationship or not, the 28-day math stays on the page:
- Patch alone at $149 every 28 days: about $1,942.32/year, or $161.86 per calendar month.
- Patch plus $39 progesterone capsules: $188 every 28 days, about $2,450.71/year, or $204.23 per calendar month.
- A 90-day window can contain four charges—days 0, 28, 56, and 84—so the scheduled total can be $596 for the patch or $752 with progesterone.
But here is why Winona can still fit the right woman: it does not create a quarterly or annual lump sum, it publishes no separate membership or consult fee, it offers 30-, 60-, or 90-day pauses, and it includes medication. Its public product page distinguishes FDA-approved patches, estrogen tablets, and progesterone capsules from compounded creams, which are not FDA-approved.
Winona is best for: an eligible woman aged 35–59 in a served state who wants an all-in recurring price, can handle a 28-day cadence, and prefers an FDA-approved patch, estrogen tablet, or progesterone capsule when clinically appropriate.
Winona is not for you if: you need financing, insurance billing, video appointments, care outside its published age or state limits, or an automatic assumption that every Winona product is FDA-approved.
Does that sound like your situation? → See Winona’s current eligibility and product options. Sponsored link — The HRT Index may earn a commission if you become a patient.
Is insurance a better answer than a payment plan?
For an insured woman, an in-network visit can beat financing because it may lower the care charge instead of merely delaying it. But “insurance accepted” still leaves three separate decisions: whether the clinic is in network, whether the prescribed drug is on your formulary, and whether the dispensing pharmacy is in network. Verify all three before comparing totals.
| Provider | Public insurance position | Current self-pay price | Important restriction |
|---|---|---|---|
| Midi | In-network with most PPO plans; coverage varies by state and plan | $250 first / $150 returning | Cannot treat Medicaid or Medi-Cal patients, even self-pay; Medicare beneficiaries may self-pay but cannot submit Midi-related claims |
| MyMenopauseRx | Accepts major insurance plans and publishes HSA/FSA eligibility | $150 per visit | Medication and labs are separate; confirm network and state availability |
| Elektra | Publishes insurance-based pricing and some Medicare/Medicaid access | $250 first / $150 returning | Availability depends on state, plan, and clinician |
| Gennev | Accepts insurance where in network | $250 first physician visit / $199 follow-up | Your plan determines cost-sharing; medication and labs are separate |
| Stella | Provides a superbill for possible reimbursement; verify current network route | $200 first / $90 follow-up | Reimbursement is not guaranteed |
Three questions, not one
- Is the visit in-network? That is about the clinic and clinician.
- Is the drug covered? That is about the formulary, indication, tier, prior authorization, and quantity limits.
- Is the pharmacy in-network? That is about where the prescription is filled.
A cash-pay telehealth clinic can still send an FDA-approved prescription to a retail pharmacy where your pharmacy benefit applies. Conversely, a covered visit does not guarantee the drug is covered. Do not let “takes insurance” collapse three separate answers into one.
Midi’s current public page verifies $250/$150 self-pay pricing and says insured responsibility varies by plan; it does not publish one universal average out-of-pocket amount. A clean number is seductive. An unsupported number is still wrong.
Does insurance sound like your strongest route? → Check Midi’s current coverage in your state before paying cash. Direct provider link. Midi cannot treat Medicaid or Medi-Cal patients, even self-pay, and is out of network with Medicare.
Can you pay for online HRT with an HSA or FSA?
Often, but card acceptance is not a tax ruling. HSA owners must keep records showing a qualified medical expense was not reimbursed elsewhere or deducted, while health FSA claims require plan substantiation. A mixed subscription can contain eligible care and noneligible extras, so ask for an itemized receipt rather than assuming the entire recurring charge qualifies.
| Provider | What the provider publishes | What you should keep |
|---|---|---|
| Winona | Accepts HSA/FSA cards and provides receipts in the patient portal | Itemized receipt, prescription record, and any plan-requested documentation |
| Midi | Accepts HSA/FSA for copays and services | Explanation of benefits, bill, and receipt |
| Alloy | Marks products HSA/FSA eligible and provides order documentation | Consult receipt and medication invoice |
| Sesame | Can provide itemized bills for reimbursement | Visit receipt, lab invoice if applicable, and pharmacy receipt |
| Inner Balance | Publishes HSA/FSA acceptance; its HSA/FSA page says those purchases are nonrefundable and outside the six-month guarantee | Itemized receipt and any administrator-requested prescription or medical-necessity documentation |
An HSA or FSA does not lower the sticker price. It changes the source of funds and may create a tax advantage. Do not advertise that advantage as a universal “25%–30% discount”; the value depends on the person’s taxes, account, plan, and eligible expense.
The provider sentence “no receipts needed” does not override IRS or plan rules. IRS Publication 969 says HSA owners must keep records. IRS guidance for health FSAs requires independent third-party substantiation where the plan does not already have enough information. Keep the receipts even when the card works.
Inner Balance deserves a specific warning here. Its HSA/FSA page says purchases made with those funds are nonrefundable and not covered by its six-month guarantee. If the guarantee is what makes you feel safe enough to try Oestra, resolve that tradeoff before choosing the card.
Are coupons or copay cards cheaper than financing?
For an eligible patient using an FDA-approved brand-name menopause medication, a manufacturer program can be more valuable than financing because it reduces the pharmacy price. Eligibility is product-specific and often excludes federal health programs. These programs do not apply to compounded preparations, and the nonhormonal options below should not be presented as interchangeable with hormone therapy.
| Medication | What it is | Published eligible-patient price | Key limit |
|---|---|---|---|
| Climara Pro | FDA-approved estradiol/levonorgestrel patch | As little as $25, maximum savings $50/month | Manufacturer terms and eligibility apply |
| VEOZAH | FDA-approved nonhormonal treatment for moderate-to-severe hot flashes | $0 first month, then as little as $30/refill for eligible commercially insured patients | Not HRT; federal-program exclusions and program limits apply |
| Osphena | FDA-approved selective estrogen receptor modulator for certain genitourinary symptoms | $35/30 tablets or $90/90 tablets through the home-delivery program for eligible commercially insured patients | Not systemic HRT; separate prices and rules apply without coverage |
A savings claim only earns the click when it names the exact product and eligibility rule: an expensive menopause drug can fall to $30 per refill under an eligible manufacturer program. A naked “$698 becomes $30” claim, without a dated source, product, insurance condition, and program limit, is not trustworthy.
Manufacturer savings and patient-assistance programs change. Re-check them immediately before filling the prescription and never treat “as little as” as your guaranteed price.
What if you skip the payment plan and fill generic prescriptions yourself?
A care-only visit plus generic medication can produce the lowest cash total when a clinician decides that regimen fits you, because the prescription remains portable and the drug can be price-shopped. Cost Plus currently lists 30 estradiol 1 mg tablets at $6.76 and 30 progesterone 100 mg capsules at $9.45, before any additional delivery or care costs.
| Cost component | Current public figure | What is not included |
|---|---|---|
| Estradiol 1 mg, 30 tablets | $6.76 | Clinician visit, other strengths/routes, and any current checkout charges |
| Progesterone 100 mg, 30 capsules | $9.45 | Clinician visit, dosing differences, and any current checkout charges |
| Listed drug-price total | $16.21 | The clinical decision, visit, labs, delivery, tax, and any additional medication |
This is not a regimen recommendation. It is a price demonstration. A clinician decides whether oral estradiol, progesterone, a patch, local vaginal treatment, a nonhormonal option, or no prescription is appropriate. The useful financial point is that a portable prescription lets you compare pharmacy prices without changing clinicians.
The cheapest page price is not always the cheapest year. A $99 visit plus inexpensive medication can beat a $149 medication bundle; it can also lose once follow-ups, labs, or a different route are added. Count the full path, not the first tile.
→ Compare full-year HRT costs by care model rather than shopping one prescription line in isolation.
Does an HRT payment plan affect your credit?
It can. “Pay in 4” and longer monthly loans are different products, so the checkout disclosure controls. Affirm publishes 0% APR for Pay in 4 and 0%–36% APR for other options. Afterpay says Pay in 4 is interest-free at partner brands, while some finance-fee transactions can carry 36% APR. Klarna terms vary by product.
| Lender fact to check | Why it matters |
|---|---|
| Product offered | Pay in 4 may be interest-free; longer financing may carry APR |
| Down payment | Some plans require money at checkout even after approval |
| Credit inquiry | A soft check may not affect a score; product-specific underwriting still applies |
| Credit reporting | Reporting varies by lender and product, and policies can change |
| Late fee or collection policy | A “no interest” product can still become expensive after a missed payment |
| Total repayment | This is the only number that can be compared honestly with the cash price |
The Consumer Financial Protection Bureau withdrew its 2024 BNPL interpretive rule on May 12, 2025. That does not mean consumers have no rights; it means you should not rely on a comparison page to promise one universal credit-card-style dispute process across every lender and product. Read the lender agreement and preserve the provider’s cancellation and refund records.
The thing nobody tells you about the button: financing approval is a credit decision, not a clinical judgment. A lender saying yes does not tell you whether the treatment, provider, formulation, or term is right.
What happens to the payments if you stop treatment?
Stopping medication, ending clinical care, canceling a subscription, obtaining a provider refund, and canceling a loan are five different events. One does not automatically trigger the others. If the provider has already processed or shipped the order, the lender can continue collecting until a refund is issued and credited under the lender’s rules.
The cleanest way to think about it is two contracts:
- Provider contract: Did you cancel before processing? Is the consult fee refundable? Has the medication shipped? Does the first-shipment guarantee apply?
- Lender contract: Has the provider issued the refund? How is that credit applied? Are future payments paused while a dispute is reviewed?
A loan does not stop when treatment does. That sentence belongs on every page that discusses medication financing.
Hers: keep the pending FTC case proportional
On July 29, 2026, the FTC and state partners sued Hims & Hers, alleging deceptive billing, cancellation, and privacy practices. The case is pending; those are allegations, not adjudicated findings. Hims & Hers says the claims are baseless and that it will defend itself. The complaint is company-wide and not proof about a particular menopause order.
The practical reason it belongs on this page is narrower: Hers advertises monthly equivalents tied to 12-month menopause plans but does not publish one universal amount due today. Read the actual checkout screen, save it, and record the cancellation path before authorizing the charge.
What are the HRT cancellation and refund deadlines?
The expensive deadline is usually the processing deadline, not the date the package arrives. Winona publishes a 24-hour order window; Alloy uses separate subscription and shipment deadlines; 1st Optimal publishes a 120-day minimum; Inner Balance excludes HSA/FSA purchases from its guarantee. The table below names the collision instead of reducing every policy to “cancel anytime.”
| Provider | Published cancel, pause, or refund term | What can still cost you |
|---|---|---|
| Winona | Full refund only within the 24-hour processing window; pause 30, 60, or 90 days | A processed 28-day refill is not refundable |
| Alloy | Subscription cancellation at least 7 days before term end; shipment change at least 5 business days before processing; first-shipment refund requests within 30 days under published terms | Consultation/service fees and later shipments can remain nonrefundable |
| Sesame | Cancel before the next monthly cycle; appointment refund rules depend on timing | Medication at the pharmacy is separate; past membership periods are not refunded |
| Inner Balance | Publishes cancel-anytime language and a six-month guarantee, but says HSA/FSA purchases are excluded | The guarantee does not protect an HSA/FSA purchase under its HSA/FSA page; dose changes may cost extra |
| Hers | Plan and order terms shown at checkout; preserve the cancellation screen | Exact first charge and plan consequences must be confirmed before purchase |
| MyMenopauseRx | Public pages have published conflicting $99 and $150 late-cancel/no-show fees | Get the current fee in writing before booking |
| 1st Optimal | Minimum 120-day commitment; cancellation or pause request at least 7 days before the next cycle after the minimum | Four-month commitment can remain even if the headline feels monthly |
| Somira | Public page says quarterly plans are not subscriptions and do not auto-renew | Financing obligations can remain until a provider refund reaches the lender |
Do not wait for a box to arrive before asking whether it is refundable. By then the relevant deadline may have passed days earlier.
What if you are on Medicare, Medicaid, or TRICARE?
Medicare creates the one major payment option missing from most telehealth comparisons: every Part D plan offers the voluntary Medicare Prescription Payment Plan. It spreads covered drug out-of-pocket costs across the calendar year without interest or participation fees, but it does not lower the total, erase a balance, cover a telehealth subscription, or make an uncovered drug covered.
| Situation | What to do first | What the payment option does not solve |
|---|---|---|
| Medicare Part D or Medicare Advantage with drug coverage | Confirm the drug is covered, then ask the plan about the Medicare Prescription Payment Plan | Visit fees, subscriptions, uncovered drugs, and prior authorization |
| Medicare beneficiary considering Midi | Midi permits self-pay but says related claims cannot be submitted to Medicare | No Medicare reimbursement for Midi visits, medications, or associated services |
| Medicaid or Medi-Cal | Check a provider that explicitly participates in your state and plan | Midi says it cannot treat Medicaid or Medi-Cal patients even as self-pay |
| Medicare or Medicaid considering Elektra | Use Elektra’s health-plan checker for your state and exact plan | Public-program acceptance is not national or universal |
| TRICARE | Check network, referral, authorization, and pharmacy benefit separately | A manufacturer card may exclude government insurance even when the drug is covered |
The Medicare Prescription Payment Plan is most useful when covered drug costs are high early in the calendar year. In 2026, Medicare’s annual out-of-pocket cap for covered Part D drugs is $2,100. The payment plan helps with timing; the cap limits covered-drug out-of-pocket spending. Neither is a telehealth provider payment plan.
For manufacturer coupons, government-insurance exclusions are common. Do not switch off a federal benefit merely to chase a coupon without first comparing the full plan consequences.
How does FDA-approved versus compounded change the payment math?
FDA-approved and compounded products must stay in separate financial lanes. FDA-approved drugs can have formularies, generic competition, retail-pharmacy portability, and manufacturer assistance. Compounded drugs are not FDA-approved; FDA does not review their safety, effectiveness, or quality before marketing. A 503A or 503B pathway describes the compounder—not FDA approval of the finished prescription.
| Payment factor | FDA-approved prescription product | Compounded prescription product |
|---|---|---|
| FDA premarket review of finished drug | Yes | No |
| Insurance/formulary route | Possible, depending on plan, indication, tier, and pharmacy | Less predictable and often excluded |
| Manufacturer copay card | Sometimes available for eligible brand products | Not available as a manufacturer card for an FDA-approved brand |
| Generic competition | Often available after approval and market entry | Not an FDA-approved generic category |
| Pharmacy portability | Often fillable at retail or mail-order pharmacies | Often tied to the prescribing program’s compounding partner |
| What to ask | Exact product name, strength, route, formulary status, and pharmacy | Exact ingredients, strength, route, compounding pharmacy, 503A/503B status, and why compounding is clinically needed |
FDA’s June 2026 telehealth guidance is unusually direct: companies should not describe a compounded drug as the same as an FDA-approved drug, call it a generic version, claim it is FDA-approved, claim equivalent clinical results, or imply an “FDA-approved” or “FDA-licensed” compounding facility. This page uses none of those descriptions.
“Bioidentical” does not settle the question. It is not an FDA approval category. Ask for the exact product and label. Some providers sell both FDA-approved and compounded options, so the provider name alone cannot tell you which one will arrive.
The Inner Balance pharmacy-status conflict
Inner Balance’s public pages did not pass a clean pharmacy-status check on August 26, 2026. Its FAQ and several treatment-page badges say 503A, while text on at least one menopause treatment page says 503B. Both pathways concern compounding; neither makes Oestra FDA-approved. Until the company reconciles the contradiction, Oestra should not receive a pharmacy-status award or an unqualified recommendation from this page.
The contradiction does not need emotional padding. A reasonable reader paying for a compounded prescription needs one answer, not two.
Which payment route fits your situation?
There is no universal winner because the best route is determined by insurance, prescription type, state, cash flow, and whether you need care or only a refill pathway. The strongest move is usually the one that lowers the total before it spreads the balance. Find your row, then verify the exact state, plan, product, and checkout terms.
| If this is you… | Start here | Why |
|---|---|---|
| Commercial PPO and a provider is in network | Insurance-billed menopause care such as Midi, MyMenopauseRx, Elektra, or Gennev | Can lower the visit cost instead of financing it |
| Commercial insurance and a brand-name drug | Manufacturer savings page for the exact FDA-approved product | Reduces pharmacy cost when eligible |
| Medicare with a covered high-cost drug | Medicare Prescription Payment Plan through your Part D plan | Spreads covered out-of-pocket drug costs without interest or fees |
| Uninsured and a generic is clinically appropriate | Care-only visit plus a portable prescription filled at a low-cost pharmacy | Lets you shop the drug separately |
| Want a flat recurring medication bundle and fit Winona’s limits | Winona’s FDA-approved patch, tablet, or capsule options when prescribed | No quarterly lump sum, but 28-day cadence and no financing |
| Want a low first care charge and local pharmacy choice | Evernow monthly, Sesame monthly, or Wisp’s three-month care access | Care and medication remain separate |
| Truly need to split a quarterly provider charge | Somira’s quarterly checkout, after reading lender and compounding disclosures | Literal public financing answer, but not our recommended default |
| Cash is tight for one or two cycles | Ask for a pause before taking a loan | A pause does not create a debt balance |
| Already stable on treatment | Price the cost of staying before switching | New intake, consults, labs, and refill gaps can erase apparent savings |
You do not need permission to choose the route that wastes less of your money. You do need enough information to know whether “less this month” becomes “more across the year.”
→ Use Find My HRT Path to narrow the care model before comparing providers — it also flags when online care is not the right starting point.
What should you ask before authorizing an HRT charge?
Get these seven answers in writing before paying. A portal message or email creates a dated record; a vague phone memory does not.
- What exact amount will be charged today? Record the monthly equivalent, plan length, and amount due today as three separate numbers.
- What is the next processing date? Ask for the date the order becomes nonrefundable, not just the billing date.
- What does the price include? Clinician care, medication, progesterone if prescribed, labs, shipping, dose adjustments, and a second prescription.
- Is the exact product FDA-approved or compounded? If compounded, ask for the pharmacy name and whether it operates under section 503A or 503B.
- What happens if the clinician says I am not a candidate? Ask what is refunded and how long it takes.
- If I finance, what are the APR, fees, dates, down payment, and total repayment? Compare the total with the cash price.
- If I stop, what must I cancel separately? Treatment, subscription, shipment, pharmacy refill, and loan can all have different steps.
Save the price screen, final checkout screen, cancellation terms, provider message, lender disclosure, and confirmation number. That folder is more useful than a comparison-page promise if something goes wrong.
When is online HRT not the right starting point?
A payment comparison cannot decide whether hormone therapy is appropriate. Systemic therapy, local vaginal treatment, nonhormonal treatment, and an in-person diagnostic evaluation solve different problems. Cost should never push a woman into the wrong treatment category, and financing approval is not medical clearance.
Two traps matter here:
- Buying systemic care for a local problem. The Menopause Society distinguishes low-dose treatment applied to the vulva or vagina for local dryness or pain from systemic estrogen that affects the whole body and can also treat hot flashes and night sweats. The right route is a clinical decision, not a checkout decision.
- Letting price disguise a product switch. Moving from an FDA-approved prescription to a compounded product solely because the bundle looks cheaper is a financial choice wearing a clinical costume. Ask which category is appropriate, then compare costs within that category.
For most women, The Menopause Society says the benefit-risk balance of hormone therapy is generally favorable when treatment begins before age 60 or within 10 years of menopause onset, but the decision still depends on individual history, symptoms, route, and risks.
If you have unexplained bleeding after menopause, get it evaluated promptly. ACOG’s 2026 guidance addresses diagnostic evaluation of postmenopausal bleeding. No subscription, lender approval, or product-page reassurance replaces that workup.
How did The HRT Index build this comparison?
This page follows The HRT Index Verification Standard: read every published price, separate FDA-approved from compounded, verify state availability and insurance, and re-check on a fixed schedule—top providers monthly and the full roster quarterly.
The five pillars are always evaluated in this order: clinical legitimacy, care quality, medication fit, price transparency, access. We do not publish numeric provider scores and did not invent one for this page.
For this audit, we:
- Checked 15 provider sites for public financing, pricing, billing cadence, inclusions, state or insurance restrictions, cancellation, refunds, and HSA/FSA language.
- Built a first-charge and 90-day ledger rather than comparing monthly-equivalent headlines.
- Recalculated every percentage and recurring-price total.
- Checked FDA, DEA, IRS, Medicare/CMS, CFPB, lender, manufacturer, ACOG, and The Menopause Society sources.
- Printed material provider-page conflicts instead of choosing the more flattering version.
- Labeled anything that requires intake or checkout as unknown rather than estimating it.
We did not pose as patients, apply for credit, fabricate a checkout, submit claims, or claim firsthand treatment experience.
Frequently asked questions about online HRT payment plans
Can you get HRT on a payment plan?
Rarely. Of 15 US online menopause and hormone-care provider sites checked on August 26, 2026, Somira was the only one publicly displaying Klarna, Affirm, and Afterpay, and it displayed them on quarterly plans. Most other providers offer subscriptions, multi-month plans, insurance billing, or care-only visits instead of financing.
Does any online menopause provider accept Affirm, Klarna, or Afterpay?
Somira publicly displayed all three on its women’s-health page for quarterly plans. We found no public menopause-specific installment option on the other 14 provider sites in the census. A private checkout can still show an option that a public page does not, so confirm the live checkout rather than treating “none published” as “impossible.”
Does Winona offer a payment plan or accept CareCredit?
No public financing option was found. Winona’s FAQ says it cannot accept CareCredit, and its 30-day supplies process every 28 days. It does offer a 30-, 60-, or 90-day pause, which can be more useful than a loan when the problem is temporary.
Is it cheaper to pay monthly or quarterly for online HRT?
At Somira, the provider in our census publishing side-by-side monthly and quarterly medication prices, quarterly reduced the three-month total by about 17% to 41%, depending on the product. For patches, the comparison was $299.99 quarterly versus $479.97 across three monthly charges—a $179.98 difference.
Can I use an HSA or FSA for online HRT?
Often, but eligibility and substantiation depend on the expense and plan. Provider card acceptance does not prove every item in a mixed subscription is qualified. HSA owners should retain records, and health FSA administrators may require independent substantiation. Keep itemized care, medication, lab, and pharmacy documentation.
Does buy now, pay later affect my credit?
It can. The answer depends on the lender and product. Affirm publishes 0% APR for Pay in 4 and 0%–36% APR for other offers; Afterpay says some finance-fee transactions can carry a 36% APR; Klarna’s checks and reporting vary by product. Read the checkout disclosure and total repayment before accepting.
What happens to installment payments if I stop the medication?
They can continue. Stopping treatment does not automatically cancel a subscription, shipment, provider order, pharmacy refill, or loan. You need the provider to issue any eligible refund and the lender to apply it. Save every cancellation confirmation and lender message.
Does Medicare have a payment plan for HRT prescriptions?
Medicare has a payment option for covered Part D drug costs, not an HRT provider financing program. Every Medicare drug plan offers the voluntary Medicare Prescription Payment Plan. It spreads covered out-of-pocket drug costs across the calendar year without interest or participation fees, but it does not lower the total or cover telehealth subscriptions.
Are there coupons or copay cards for menopause medication?
Yes, for certain FDA-approved brand-name products and eligible patients. Current examples include Climara Pro as little as $25, VEOZAH $0 for the first month and as little as $30 per refill for eligible commercially insured patients, and Osphena $35 for 30 tablets through its home-delivery program. Terms and exclusions apply.
How much can generic estradiol and progesterone cost without insurance?
Cost Plus currently lists 30 estradiol 1 mg tablets at $6.76 and 30 progesterone 100 mg capsules at $9.45, a listed drug-price total of $16.21 before any additional checkout, delivery, visit, lab, or other medication cost. That is a price example, not a treatment recommendation.
Does Medicaid cover online menopause care?
It depends on the provider, state, and plan. Midi says it cannot treat Medicaid or Medi-Cal patients even as self-pay. Elektra publishes Medicare and Medicaid access in some state-and-plan combinations. Verify the exact plan before completing intake.
Can I pause an HRT subscription instead of canceling it?
At some providers, yes. Winona publishes 30-, 60-, and 90-day pauses. A pause can solve a temporary cash-flow problem without creating a loan, but check whether the prescription remains valid and when billing automatically restarts.
What is the cheapest way to get HRT online?
There is no universal cheapest route. An insured in-network visit can lower clinical-care cost; a manufacturer card can lower an eligible brand drug; a care-only visit plus a portable generic prescription can lower cash cost; and a medication bundle can reduce coordination. Compare the first charge, 90-day total, medication, labs, and follow-up—not the headline alone.
Still not sure which HRT program is right for you? Take our free 90-second matching quiz. No email required.
Primary sources and verification links
Provider pricing, payment, and policy pages
- Somira Health women’s-health pricing and payment options — verified August 26, 2026.
- Winona FAQ: availability, age, insurance, HSA/FSA, CareCredit, billing cadence, refunds, and pause — verified August 26, 2026.
- Winona HRT products and prices — verified August 26, 2026.
- Midi pricing and insurance — verified August 26, 2026.
- Sesame menopause treatment — verified August 26, 2026.
- Alloy estradiol patch and Alloy terms — verified August 26, 2026.
- Hers menopause treatment cost — verified August 26, 2026.
- Inner Balance perimenopause pricing, menopause page, HRT page, FAQ, and HSA/FSA page — verified August 26, 2026.
- Wisp menopause care — verified August 26, 2026.
- Evernow pricing — verified August 26, 2026.
- MyMenopauseRx treatment costs — verified August 26, 2026.
- Elektra menopause medical care and health plans — verified August 26, 2026.
- Gennev plans — verified August 26, 2026.
- Stella FAQ and insurance page — verified August 26, 2026.
- Henry Meds hormone therapy — verified August 26, 2026.
- 1st Optimal terms and conditions — verified August 26, 2026.
Regulatory, tax, credit, and Medicare sources
- FDA: Human Drug Compounding — current FDA language on approval and premarket review.
- FDA: What telehealth companies should know when promoting compounded drugs — current promotion language.
- DEA drug scheduling — controlled-substance framework; testosterone is listed under federal Schedule III steroid controls.
- IRS Publication 969 — HSA recordkeeping and qualified-expense rules.
- IRS Information Letter 2021-0003 — health FSA substantiation.
- Medicare Prescription Payment Plan, before using the option, and using the option — verified August 26, 2026.
- CMS 2026 Part D redesign — $2,100 2026 out-of-pocket threshold.
- CFPB enforcement announcement concerning BNPL and withdrawn guidance list — verified August 26, 2026.
- Affirm payment options, Klarna customer service, and Afterpay: how it works — verified August 26, 2026.
- FTC complaint announcement concerning Hims & Hers and Hims & Hers response — July 29, 2026.
Medical and savings-program sources
- The Menopause Society: Hormone Therapy and Sexual Health — systemic/local treatment distinctions and individualized benefit-risk framing.
- ACOG: 2026 guidance on evaluating postmenopausal bleeding.
- Climara Pro savings, VEOZAH savings, and Osphena savings — verified August 26, 2026.
- Cost Plus estradiol 1 mg and progesterone 100 mg — verified August 26, 2026.
This page is editorial research and was not reviewed by a clinician. It is educational only and is not medical, tax, insurance, or financial advice. Treatment decisions belong to you and a licensed clinician. Financing approval, HSA/FSA eligibility, insurance coverage, and savings-program eligibility depend on the specific provider, lender, plan, product, and individual circumstances.
